The board of directors of Shandong Weigao Group Medical Polymer Company Limited announced the following changes to the Board: Mr. Wang Yi, an executive director, is re-designated as a non-executive director of the company with effect from August 29, 2018; Mr. Wang has tendered resignation as the Chief Executive Officer of the company with effect from August 29, 2018; Mr. Long Jing has been proposed to be appointed as an executive director of the company subject to the approval by the shareholders of the company at the upcoming special general meeting or any adjournment thereof; and Mr. Long has been appointed as the Chief Executive Officer of the company with effect from August 29, 2018. The Board of the company announced that Mr. Wang has resigned as the Chief Executive Officer of the company and re-designated as a non-executive director with effect from August 29, 2018. The Board also announced that Mr. Long Jing has been proposed to be appointed as an executive director of the company subject to the approval by the shareholders of the company at the upcoming special general meeting or any adjournment thereof.

Mr. Long has also been appointed as the Chief Executive Officer of the company with effect from August 29, 2018. Mr. Long Jing currently is Chief Executive Officer of the company. Prior to joining the company, Mr. Long joined (Shandong Plastic Materials Industry Company) from 1996 to 2002 and served as the sales chief and was principally responsible for the sales and marketing of raw materials.

From March 2013 to June 2016, Mr. Long served as an employee representative supervisor of the Company. At the same time, Mr. Long is a certified public accountant in the PRC and has over 10 years of valuable experiences in sales and marketing in China.